Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 35,780 shares at $16.93 ($606K) on 2014-12-18, disclosed to the SEC on 2014-12-18.
Scheduled sale ($606k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.94 | 12,500 | $212K | 34.9% |
| 2 | $16.94 | 17,500 | $296K | 48.9% |
| 3 | $16.93 | 5,780 | $98K | 16.1% |
| Total | $16.94 avg | 35,780 | $606K | 100% |
| Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |
| AVNR | SELL | 2014-05-16 | $189K | — | Filing → |